Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wheatcroft, N. J.
Right arrow Articles by Weetman, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wheatcroft, N. J.
Right arrow Articles by Weetman, A. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 12, 2617-2622, Copyright © 1997 by Oxford University Press


ARTICLES

Identification of ovarian antibodies by immunofluorescence, enzyme- linked immunosorbent assay or immunoblotting in premature ovarian failure

NJ Wheatcroft, C Salt, A Milford-Ward, ID Cooke and AP Weetman
Department of Medicine, Northern General Hospital, University of Sheffield, UK.

The development of new techniques for the detection of ovarian antibodies has challenged early concepts about the rarity of ovarian antibodies in idiopathic premature ovarian failure (POF), but few attempts have been made to compare results between assays. We have sought to define the prevalence of ovarian autoimmunity in a group of 30 idiopathic POF patients compared to a group of 12 patients with POF plus an associated autoimmune disease and a group of 38 controls, using an enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence (IFL). Ovarian antibodies were detected in 27% of idiopathic POF patients by ELISA (not significantly different compared to POF patients with associated autoimmune disease; P < 0.0003 compared to controls) but only 7% of these patients were positive by IFL. In a further, pre-selected group of individuals, all positive for ovarian antibodies by IFL, 53% had measurable antibodies by ELISA. Some overlap was therefore demonstrated between the two techniques but many POF patients had ovarian antibodies detectable by only one method. Immunoblotting studies revealed that no consistent pattern of binding could be demonstrated for these patients. These results call into question the specificity of ovarian antibodies as a marker for autoimmune POF.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. Tsigkou, S. Marzotti, L. Borges, A. Brozzetti, F. Reis, P. Candeloro, M. Luisa Bacosi, V. Bini, F. Petraglia, and A. Falorni
High Serum Inhibin Concentration Discriminates Autoimmune Oophoritis from Other Forms of Primary Ovarian Insufficiency
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1263 - 1269.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. S. Pires, P. K. Meherji, R. R. Vaidya, F. R. Parikh, M. N. Ghosalkar, and V. V. Khole
Specific and Sensitive Immunoassays Detect Multiple Anti-ovarian Antibodies in Women With Infertility
J. Histochem. Cytochem., December 1, 2007; 55(12): 1181 - 1190.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C.A.A. Silva and H.I. Brunner
Review: Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus
Lupus, August 1, 2007; 16(8): 593 - 599.
[Abstract] [PDF]


Home page
J. Histochem. Cytochem.Home page
E. S. Pires, P. P. Parte, P. K. Meherji, S. A. Khan, and V. V. Khole
Naturally Occurring Anti-albumin Antibodies Are Responsible for False Positivity in Diagnosis of Autoimmune Premature Ovarian Failure
J. Histochem. Cytochem., April 1, 2006; 54(4): 397 - 405.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. Goswami and G. S. Conway
Premature ovarian failure
Hum. Reprod. Update, July 1, 2005; 11(4): 391 - 410.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
T. Forges, P. Monnier-Barbarino, G.C. Faure, and M.C. Bene
Autoimmunity and antigenic targets in ovarian pathology
Hum. Reprod. Update, March 1, 2004; 10(2): 163 - 175.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z.-B. Tong and L. M. Nelson
A Mouse Gene Encoding an Oocyte Antigen Associated with Autoimmune Premature Ovarian Failure
Endocrinology, August 1, 1999; 140(8): 3720 - 3726.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
S.N. Kalantaridou, D.T. Braddock, N.J. Patronas, and L.M. Nelson
Treatment of autoimmune premature ovarian failure: Case report
Hum. Reprod., July 1, 1999; 14(7): 1777 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Ishizuka, Y. Kudo, A. Amemiya, H. Yamada, T. Matsuda, and T. Ogata
Anti-nuclear antibodies in patients with premature ovarian failure
Hum. Reprod., January 1, 1999; 14(1): 70 - 75.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.